PMC:7128678 / 1267-1373 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"56","span":{"begin":5,"end":15},"obj":"Species"},{"id":"64","span":{"begin":33,"end":45},"obj":"Chemical"},{"id":"65","span":{"begin":50,"end":62},"obj":"Chemical"}],"attributes":[{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"Tax:2697049"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:D012794"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D005732"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of gangliosi"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T38","span":{"begin":5,"end":15},"obj":"SP_7"},{"id":"T39","span":{"begin":33,"end":45},"obj":"CHEBI:26667;CHEBI:26667"},{"id":"T40","span":{"begin":50,"end":62},"obj":"CHEBI:5386;CHEBI:5386"}],"text":" for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of gangliosi"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T7","span":{"begin":50,"end":62},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma82816"}],"text":" for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of gangliosi"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T8","span":{"begin":5,"end":13},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of gangliosi"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":83,"end":84},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of gangliosi"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T16","span":{"begin":33,"end":45},"obj":"Chemical"},{"id":"T17","span":{"begin":40,"end":45},"obj":"Chemical"},{"id":"T18","span":{"begin":50,"end":62},"obj":"Chemical"}],"attributes":[{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_26667"},{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A18","pred":"chebi_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/CHEBI_28892"}],"text":" for SARS-CoV-2 treatment, binds sialic acids and gangliosides with high affinity. A new type of gangliosi"}